Abstract:Significance Statement Although reports indicate that patients receiving maintenance hemodialysis are at risk for severe illness with coronavirus disease 2019 (COVID-19), information about this population of patients is limited. Using data retrospectively collected from a registration system that included 7154 patients undergoing hemodialysis at 65 hospitals in Wuhan, China, the authors found that 154 patients had laboratory-confirmed COVID-19. In a detailed analysis of epidemiologic and clinical characteristics for 131 COVID-19 patients who provided oral consent, they showed that hemodialysis centers are high-risk settings for COVID-19, and described interventions that effectively prevented COVID-19 spread among patients at such centers. These measures included requiring patients to wear a medical mask during dialysis and in public, conducting universal screening for the infection, and isolating infected patients and directing them to designated hemodialysis centers. Background Reports indicate that those most vulnerable to developing severe coronavirus disease 2019 (COVID-19) are older adults and those with underlying illnesses, such as diabetes mellitus, hypertension, or cardiovascular disease, which are common comorbidities among patients undergoing maintenance hemodialysis. However, there is limited information about the clinical characteristics of hemodialysis patients with COVID-19 or about interventions to control COVID-19 in hemodialysis centers. Methods We collected data retrospectively through an online registration system that includes all patients receiving maintenance hemodialysis at 65 centers in Wuhan, China. We reviewed epidemiologic and clinical data of patients with laboratory-confirmed COVID-19 between January 1, 2020 and March 10, 2020. Results Of 7154 patients undergoing hemodialysis, 154 had laboratory-confirmed COVID-19. The mean age of the 131 patients in our analysis was 63.2 years; 57.3% were men. Many had underlying comorbidities, with cardiovascular disease (including hypertension) being the most common (68.7%). Only 51.9% of patients manifested fever; 21.4% of infected patients were asymptomatic. The most common finding on chest computed tomography (CT) was ground-grass or patchy opacity (82.1%). After initiating comprehensive interventions?including entrance screening of body temperature and symptoms, universal chest CT and blood tests, and other measures?new patients presenting with COVID-19 peaked at 10 per day on January 30, decreasing to 4 per day on February 11. No new cases occurred between February 26 and March 10, 2020. Conclusions We found that patients receiving maintenance hemodialysis were susceptible to COVID-19 and that hemodialysis centers were high-risk settings during the epidemic. Increasing prevention efforts, instituting universal screening, and isolating patients with COVID-19 and directing them to designated hemodialysis centers were effective in preventing the spread of COVID-19 in hemodialysis centers.

Clinical Manifestations of COVID-19 Infection in Dialysis Patients and Protective Effect of COVID-19 Vaccine

Immunogenicity and safety of SARS-CoV-2 vaccine in hemodialysis patients: A systematic review and meta-analysis.

COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment

Protective Effect of COVID-19 Vaccines on Dialysis Patients with Chronic Kidney Disease: a Meta-Analysis

An overview of clinical studies on SARS-CoV-2 infection in dialysis patients

Clinical outcomes of dialysis patients with COVID-19 in the initial phase of the COVID-19 outbreak in Wuhan, China

Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.

[Clinical Characteristics of COVID-19 Infection in Patients Undergoing Hemodialysis].

Clinical characteristics of 31 hemodialysis patients with 2019 novel coronavirus: a retrospective study

Impact of COVID-19 Vaccination on Mortality and Clinical Outcomes in Hemodialysis Patients

Impact of the COVID-19 pandemic on patients with chronic kidney disease A narrative review

COVID-19 and Chronic Renal Disease: Clinical Characteristics and Prognosis

Clinical Features and Risk Factors for Outcome in Hemodialysis Patients with COVID-19 after Complete Liberalization of Epidemic Control in China

Mortality rate of COVID-19 infection in end stage kidney disease patients on maintenance hemodialysis: A systematic review and meta-analysis

COVID-19 in patients undergoing long-term dialysis in Ontario

An update on the interaction between COVID-19, vaccines, and diabetic kidney disease

COVID-19 epidemic investigation study of a follow-up cohort of patients with diabetic kidney disease

Risk factors for mortality and antibody responses in chronic hemodialysis patients with coronavirus disease 2019: a single-center experience in China

Risk factors and prognosis for coronavirus disease 2019 among 131 hemodialysis patients during the Omicron variant epidemic

SARS-CoV-2 and dialysis: humoral response, clinical and laboratory impacts before vaccination

COVID-19 in Hemodialysis Patients: A Report of 5 Cases